NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE157527 Query DataSets for GSE157527
Status Public on Dec 14, 2020
Title CRISPR screen identifies genes that sensitize AML cells to double negative T cell therapy [guide RNA]
Organism Homo sapiens
Experiment type Other
Summary Here, we used a targeted CRISPR/Cas9 screen to identify genes that confer susceptibility of AML cells to DNT cell therapy.
 
Overall design The CRISPR screen employed in our pooled Epidrug library consisted of ~12,500 sgRNAs targeting 317 epigenetic regulators, 657 FDA-approved drug targets based on Drugbank v4.3, and control genes, with 10 sgRNAs per gene on average. The sgRNAs were designed using the CRISPR-DO tool. Stable Cas9-expressing cell lines (AML2 and AML3) were generated. Cas9-expressing AML cell lines were infected with the library at an MOI of ~ 0.3 and coverage of 300x. 24-48h post-infection, cells were selected with puromycin for 72h and then cultured for ~7 days, maintaining 300x coverage prior to our screening assay. To detect early apoptotic AML cells, we co-incubated the transduced AML3 cells with DNTs at a 1:1 E:T ratio for 2h to induce apoptosis in ~40-50% of the targets, depleted DNTs by magnetic separation, and performed FACS to separate Annexin V+ (live) and Annexin V- (dead or dying) target cells. Genomic DNA was extracted from replicate samples and sgRNA inserts were amplified by PCR. The input amount of genomic DNA was calculated to achieve 250x coverage of the library and resulting libraries were sequenced on an Illumina HiSeq2500.
 
Contributor(s) He HH
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Sep 04, 2020
Last update date Dec 14, 2020
Contact name Musaddeque Ahmed
E-mail(s) musaddeque.ahmed@gmail.com
Organization name University health Network
Lab He Lab
Street address 101 College St
City Toronto
State/province ON
ZIP/Postal code M5G1L7
Country Canada
 
Platforms (1)
GPL16791 Illumina HiSeq 2500 (Homo sapiens)
Samples (16)
GSM4769391 AML3_noDNT_rep1
GSM4769392 AML3_noDNT_rep2
GSM4769393 AML3_postDNT_rep1
This SubSeries is part of SuperSeries:
GSE157618 CRISPR screen identifies genes that sensitize AML cells to double negative T cell therapy
Relations
BioProject PRJNA661568
SRA SRP280155

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE157527_AML2_postDNT_vs_noDNT.gene_summary.txt.gz 41.2 Kb (ftp)(http) TXT
GSE157527_AML3_D7pre_vs_D0.gene_summary.txt.gz 42.3 Kb (ftp)(http) TXT
GSE157527_AML3_postDNT_vs_noDNT.gene_summary.txt.gz 41.6 Kb (ftp)(http) TXT
GSE157527_crispr_library.csv.gz 110.9 Kb (ftp)(http) CSV
GSE157527_live_vs_dead.gene_summary.txt.gz 32.8 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap